Programme

Topics

Topic 1 - Myotonic disorders (DM1/DM2 and non-dystrophic myotonias), basic biology and treatment options

Topic 2 - Drug-induced and infectious myopathies

Topic 3 - Trust, transparency and therapeutic understanding

Each day of WMS 2026 a plenary session will be dedicated to exploring one of these topics. Speakers will summarise the state of the field on the selected topics and cover key aspects.

Speaker selection policy: When choosing speakers for the WMS Congresses, we aim to achieve a fair balance in terms of gender, geographic representation, and areas of expertise based on the key topics agreed upon by the Programme Committee.

In response to specific feedback from attendees, and to provide a diverse range of expert speakers, symposia speakers and chairs are not allowed to participate in more than one symposium at the Congress.

Additionally, invited speakers and moderators are not permitted to speak at industry symposia.

Advertising activities at WMS 2026 are restricted to pharmaceuticals and medical devices authorised for marketing in Japan, and all claims must remain strictly within the approved labelling and intended use (on-label); promotion of unapproved products and off-label use is not permitted.

WMS EDI Statement: The World Muscle Society is committed to creating an equitable, diverse, and inclusive environment for researchers and clinicians to learn, share ideas, and promote translational science for the benefit of patients with neuromuscular disorders. As such, the WMS Programme Committee encourages all speakers and attendees, to use respectful language, to consider the diverse backgrounds, culture, and native language of our membership, and reflect on the diversity and inclusion in their presented work and its impact on the generalisability of findings for all patients with neuromuscular disorders.

Congress Programme

  • The summary and full programme will be available to download as a PDF document below;
  • The sessions will comprise invited speakers, selected oral presentations, a debate, poster highlights and late breaking news; and delegates will have the opportunity to attend poster presentations and interact with presenters
  • WMS 2026 Poster Sessions, Short Oral Presentations, Clinical Trial Updates and Industry Symposia are not EACCME accredited. Details of these sessions will be published as an appendix to the full Congress programme.

 

Summary Congress Programme

 

Full Congress Programme

 

Full Programme (downloadable version)

 

ePoster presentation schedule

 

Programme Key:

I = Invited Speaker
O/LBO = Selected Oral Presentation/Late Breaking Selected Oral Presentation
SP = Short Oral Presentation
P/LBP = Poster Presentation/Late Breaking Poster Presentation (on display at the venue and on the virtual platform)
eP = ePoster Presentation
VP/LBVP = Virtual Poster Presentation/ Late Breaking Virtual Poster Presentation (on display on the virtual platform and on ePoster boards at the venue)

1.01P for example represents poster session 1, and then poster 01 in that session.

Further information on the different types of poster presentations will be available soon.

Please note, all times listed in the programme are shown in Local Hiroshima, Japan (JST) time.

WMS Facebook Feed
World Muscle Society